Abiopharma

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013046 <b>Size:</b> 244 KB

Annual Reports and Related Documents:

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025222 <b>Size:</b> 1 MB

Teva Pharmaceutical Industries Ltd. -Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

New Form 424B3 - RedCloud Holdings plc <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001493152-26-040520 <b>Size:</b> 75 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025221 <b>Size:</b> 932 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Changes in Interest of Substantial Shareholder

General Announcement: TMG - FY2026 Results Briefing

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

New Form N-PX - Calamos Long/Short Equity & Dynamic Income Trust <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001438934-26-002271 <b>Size:</b> 380 KB

New Form DEF 14C - CLEARONE INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001753926-26-001652 <b>Size:</b> 291 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Changes in Interest of Substantial Shareholder

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025220 <b>Size:</b> 432 KB

New Form N-23C-2 - OFS Capital Corp <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001487918-26-000085 <b>Size:</b> 24 KB

General Announcement: Share Buy-Back